A recent groundbreaking study published in The Lancet Obstetrics, Gynaecology & Women's Health has brought much-needed clarity and reassurance to pregnant women worldwide. The research, conducted by a renowned international team, has put an end to the anxiety surrounding paracetamol use during pregnancy. But here's where it gets controversial: despite previous claims suggesting a link, this extensive review found no evidence to support the idea that paracetamol increases the risk of autism, ADHD, or intellectual disability in children.
The study analyzed an impressive amount of global data, employing the most rigorous methods to date. By focusing on sibling comparison studies, the researchers were able to account for genetic and environmental factors, providing a more accurate picture of the drug's safety. The results were clear: when used as directed, paracetamol remains a safe and effective option for managing pain and fever during pregnancy.
But why did earlier studies cause confusion? In September 2025, claims emerged suggesting a potential link between paracetamol and autism risk. While some studies reported small associations, the authors of this new review highlight that these findings were often based on less robust study designs. Many failed to consider important factors like maternal illness, fever, family history, and genetics, all of which can influence child development. By excluding lower-quality evidence and focusing on sibling comparisons, the researchers concluded that earlier links were likely due to bias or unmeasured confounding, rather than a true causal effect of paracetamol.
This research is particularly relevant for pregnant women in the UK, where paracetamol is the most commonly recommended painkiller. It's considered safer than alternatives like ibuprofen or opioid painkillers, and doctors emphasize that untreated fever or severe pain during pregnancy can pose their own risks. Avoiding paracetamol unnecessarily could, therefore, be more harmful than beneficial.
The findings align with existing advice from reputable sources like the NHS, the Medicines and Healthcare products Regulatory Agency, and the Royal College of Obstetricians and Gynaecologists. All continue to recommend paracetamol as the first-line option during pregnancy when used at the lowest effective dose.
This study also addresses the ongoing debate in the US, where claims about Tylenol (the US brand name for paracetamol) have been linked to misinformation about autism. Mel Merritt, Head of Policy and Campaigns at the National Autistic Society, warned last year about the real-world impact of spreading fear among expectant parents. She emphasized that painkillers and vaccines do not cause autism, and large-scale studies have shown no robust scientific evidence to support such claims.
So, what should pregnant women take away from this research? The message is simple and reassuring: based on the best available evidence, taking paracetamol as advised during pregnancy is not linked to autism, ADHD, or intellectual disability. Health experts continue to recommend it as a safe and effective option for pain and fever relief. If you have any concerns about medication during pregnancy, it's always best to consult your GP or midwife, but this study provides strong reassurance at a time when many expectant mothers have felt anxious and confused.
Remember, it's important to make informed decisions during pregnancy, and this study offers valuable insights to help you do just that.
